It has been interesting to see how market commentary seems to have shifted as much as possible away from COVID-related news since the beginning of the year. In one sense, I think that could be a good thing, since there are a lot of issues, economic, political, and otherwise that are worthy of attention. This […]
Read MoreFor most of the past year, any examination of the Pharmaceutical industry begins and ends with COVID-19 vaccines. Literally, of course, this isn’t true; diseases of all kinds don’t take a holiday during a pandemic, and so development of existing projects for any company in this industry hasn’t stopped, either. Nonetheless, the massive, immediate impact […]
Read MoreSince the beginning of the year, broad market momentum has mostly stalled. Investors seem to be confronting the reality that the pandemic’s economic effects appear set to linger well into the rest of this year, even as vaccinations across the country begin to increase and new vaccine candidates appear ready to apply for emergency use […]
Read MoreOne of the sectors that has seen an impressive rally over the last couple of months is the Energy sector. As measured by the U.S. Energy iShares ETF (IYE), the sector has increased from a trend low point at the end of October by about 54%. Much of that increase has been driven by a […]
Read MoreOne of the challenges that investors have had to deal with throughout the past year is the market’s divergence from economic facts on the ground. From the early stages of the pandemic, analysts could not agree whether the expected, eventual recovery from both a health and economic-driven perspective would manifest as by a move back […]
Read MoreUncertain economic conditions have proven to be a good time to think about stocks that most people tend to overlook because they’re “boring.” These are stocks that also tend to operate in counter-cyclical fashion. It’s been interesting – but not surprising – to see a bit of a resurgence in stocks in the Food Products […]
Read MoreMoving closer and closer to Christmas means that most people’s focus is on end-of-the-year celebrations and time with family. I think that’s true this year, even though for many of us 2020 has meant maintaining distance from family members and loved ones; for me and my family, that has also impacted our normal, end-of-the-year massive […]
Read MoreThe Consumer Discretionary sector includes stocks that cover a wide variety of the Retail industry. Because there are so many retail companies that offer different products to consumers, it’s hard to pinpoint any kind of specific niche. In the sporting goods niche, there were significant challenges even before COVID-19 became a global pandemic. Declining revenues […]
Read MoreEver since coronavirus found its way to American shores, a large amount of media attention has been given to the Healthcare sector – and especially to the Biotechnology industry, where many of the biggest names across the world have been working hard to develop effective treatments for the disease. From the market’s bearish low in […]
Read MoreOne of the big headlines to start the week has been the long-anticipated FDA approval of the first coronavirus vaccine in the United States. News media were all over shipping companies in the early hours of market trading today outlining in detail how the vaccine was being distributed on a nationwide basis. The scrutiny and […]
Read MoreBuy Price: $130.00 or better Sell Price: TradersPro Sell Signal Novavax, Inc., together with its subsidiary, Novavax AB, a late-stage biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. The company’s lead vaccine candidates include ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate that […]
Read MoreOne of the hardest-hit sectors of the market this year is the Energy sector. While COVID-19 has dominated headlines throughout the year, and indeed has contributed to a massive decline in demand for petroleum products all over the globe as shelter-in-place orders have forced a massive shift for most corporations to remote work, the fact […]
Read MoreI hope everybody had a wonderful Thanksgiving holiday! I’ve written a lot in this space about my belief in defensive sectors and industries for more than a year now. The market is showing a lot of bullish momentum right now, but I think the initial relief that I attribute mostly to decreasing political uncertainty is […]
Read MoreBlack Friday means that the market’s attention, along with most consumers is squarely focused on the retail segment. It is interesting to observe the way that retailers have adjusted their Black Friday operations around the limitations and uncertainty attached to the coronavirus pandemic. Those measures have not surprisingly pushed some of the conversation back in […]
Read MorePost-election, a lot of the focus for the markets has, not surprisingly shifted back to COVID and the pandemic that just won’t stop. Concern is increasing that the colder months of the year will make things even worse, and that a health care system that is already being strained as infections and hospitalizations are pushing […]
Read More